Correction: HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients [Cardiovasc Diabetol, 79, (2013) (12)] DOI: 10.1186/1475-2840-12-79;HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Hjellestad, Iren D ^a   Astor, Marianne C ^a   Nilsen, Roy M ^a   Søfteland, Eirik ^a   Jonung, Torbjørn ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Diabetes mellitus; HbA1c; OGTT; Peripheral arterial disease

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; ADULT; AGED; ANALYSIS; BLOOD; COMPARATIVE STUDY; FEMALE; GLUCOSE TOLERANCE TEST; MALE; MIDDLE AGED; NORWAY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; PREOPERATIVE CARE; REPRODUCIBILITY; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NORWAY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84878009842     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-018-0686-z     Document Type: Erratum

References (33)

1. World health Organization Department of Noncommunicable Disease Surveillance, Geneva Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation 2006, http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf, World health Organization Department of Noncommunicable Disease Surveillance, Geneva.
2. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003, 121:245-251. 10.1001/archopht.121.2.245, 12583792.
3. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008, 31:1349-1354. 10.2337/dc07-1707, 2453668, 18411241.
4. Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2011, 60:298-305. 10.2337/db10-1198, 3012185, 20978092.
5. Sabanayagam C, Liew G, Tai ES, Shankar A, Lim SC, Subramaniam T. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia 2009, 52:1279-1289. 10.1007/s00125-009-1360-5, 19387611.
6. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2006, 29:877-882. 10.2337/diacare.29.04.06.dc05-2018, 16567831.
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
8. The International Expert Committee International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32(7):1327-1334. 2699715, 19502545, The International Expert Committee.
9. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69. 2797383, 20042775, American Diabetes Association.
10. World health Organization Department of Noncommunicable Disease Surveillance, Geneva Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation 2011, http://www.who.int/cardiovascular_diseases/report-hba1c_2011_edited.pdf, World health Organization Department of Noncommunicable Disease Surveillance, Geneva.
11. Rein P, Beer S, Saely CH, Vonbank A, Drexel H. Prevalence of impaired glucose metabolism in individuals with peripheral arterial disease. Int J Cardiol 2010, 144:243-244. 10.1016/j.ijcard.2009.01.002, 19193459.
12. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743. 10.1161/01.CIR.0000137913.26087.F0, 15262830.
13. Astor M, Softeland E, Daryapeyma A, Jonung T. Dysglycaemia in vascular surgery patients. Eur J Vasc Endovasc Surg 2010, 39:447-451. 10.1016/j.ejvs.2009.12.005, 20149695.
14. Midthjell K. CMYLCPSC. Comparison of HbA1c and OGTT in the diagnosis of diabetes in a high-risk population. The HUNT-DE-PLAN Study 2010, Stockholm, Norway, Oral presentation at The EASD Annual Meeting 2010.
15. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33:562-568. 10.2337/dc09-1524, 2827508, 20067953.
16. Rathmann W, Kowall B, Tamayo T, Giani G, Holle R, Thorand B. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study. Ann Med 2012, 44(2):170-177. Epub 2010 Nov 22, 10.3109/07853890.2010.531759, 21091229.
17. Peter A, Fritsche A, Stefan N, Heni M, Haring HU, Schleicher E. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes 2011, 119:234-237. 10.1055/s-0030-1270440, 21264802.
18. Stene LC, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E. Prevalence of diabetes mellitus in Norway. Tidsskr Nor Laegeforen 2004, 124:1511-1514.
19. Midthjell K, Bjorndal A, Holmen J, Kruger O, Bjartveit K. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trondelag Diabetes Study. Scand J Prim Health Care 1995, 13:229-235. 10.3109/02813439508996766, 7481177.
20. Doerr R, Hoffmann U, Otter W, Heinemann L, Hunger-Battefeld W, Kulzer B. Oral glucose tolerance test and HbAc for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 2011, 54:2923-2930. 10.1007/s00125-011-2253-y, 21773683.
21. Lauritzen T, Sandbaek A, Skriver MV, Borch-Johnsen K. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark. Diabetologia 2011, 54:1318-1326. 10.1007/s00125-011-2077-9, 21340624.
22. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. Is haemoglobin A1c a step forward for diagnosing diabetes?. BMJ 2009, 339:b4432. 10.1136/bmj.b4432, 19903702.
23. Lilleholt K, Hallberg MH, Hagve TA. [Hemoglobinopathies and patients with foreign names]. Tidsskr Nor Laegeforen 2005, 125:1164-1167.
24. Ye Y, Xie H, Zhao X, Zhang S. The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy. Cardiovasc Diabetol 2012, 11:155. 10.1186/1475-2840-11-155, 3534587, 23270530.
25. Mostafa SA, Davies MJ, Webb D, Gray LJ, Srinivasan BT, Jarvis J. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus. Diabet Med 2010, 27:762-769. 10.1111/j.1464-5491.2010.03015.x, 20636956.
26. Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 2009, 32:828-833. 10.2337/dc08-1699, 2671106, 19196895.
27. Martins RA, Jones JG, Cumming SP, Silva MJ CE, Teixeira AM, Verissimo MT. Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol 2012, 11:13. 10.1186/1475-2840-11-13, 3395860, 22309488.
28. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006, 29:1619-1625. 10.2337/dc05-2525, 16801588.
29. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811. 10.1056/NEJMoa0908359, 2872990, 20200384.
30. Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007, 120:720-727. 10.1016/j.amjmed.2007.03.022, 2585540, 17679132.
31. Van't RE, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010, 33:61-66. 10.2337/dc09-0677, 2797987, 19808928.
32. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004, 25:1880-1890. 10.1016/j.ehj.2004.07.027, 15522466.
33. Cederberg H, Saukkonen T, Laakso M, Jokelainen J, Harkonen P, Timonen M. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010, 33:2077-2083. 10.2337/dc10-0262, 2928368, 20573752.